Literature DB >> 15994151

Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network.

Isabelle Ray-Coquard1, Thierry Philip, Guy de Laroche, Xavier Froger, Jean-Philippe Suchaud, Alain Voloch, Hélène Mathieu-Daudé, Antoine Lurkin, Fadila Farsi, Pierre Bertrand, Franck Chauvin.   

Abstract

PURPOSE: A cancer network of general or private hospitals of a French region was started in 1995 for improving quality of care and rationalizing medical prescriptions. The impact of implementing a clinical practice guidelines (CPG) project assessed conformity with guidelines in medical practice; significant changes were observed within the network, whereas no changes were observed in a control region without cancer network. In the present study, we evaluated the persistence of conformity to guidelines through a new medical audit. PATIENTS AND METHODS: In 1999, the hospitals of the previously compared experimental and control groups accepted to reassess the impact of CPG. A controlled transversal study was performed in the experimental group (cancer network) and in the control group (no regional cancer network). In 1996 (first audit) and in 1999 (present audit), all new patients with colon cancer (177 and 200 in experimental group and 118 and 100 in control group, respectively) and early breast cancer (444 and 381 in experimental group and 172 and 204 in control group, respectively) were selected.
RESULTS: In the experimental group, the compliance of medical decisions with CPG was significantly higher in 1999 than in 1996 for colon cancer (73%; 95% CI, 67% to 79% v 56%; 95% CI, 49% to 63%, respectively; P = .003) and similar for the two periods for breast cancer (36%; 95% CI, 31% to 41% v 40%; 95% CI, 35% to 44%, respectively; P = .24). In the control group, compliance was significantly higher in 1999 than in 1996 for colon cancer (67%; 95% CI, 58% to 76% v 38%; 95% CI, 29% to 47%, respectively; P < .001) and identical for the two periods for breast cancer (4%; 95% CI, 1% to 7% v 7%; 95% CI, 3% to 11%, respectively; P = .19).
CONCLUSION: The CPG program for cancer management produced persistent changes in medical practice in our cancer network in terms of conformity with CPG.

Entities:  

Mesh:

Year:  2005        PMID: 15994151     DOI: 10.1200/JCO.2005.01.040

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

1.  Canadian breast cancer guidelines are as effective as possible under the circumstances.

Authors:  Eva Grunfeld
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

2.  Clinical practice guidelines for cancer care: what are they for?

Authors:  Paula Manchon Walsh; Josep M Borràs
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

Review 3.  Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.

Authors:  Robin K Kelley; Stephanie L Van Bebber; Kathryn A Phillips; Alan P Venook
Journal:  J Natl Compr Canc Netw       Date:  2011-01       Impact factor: 11.908

4.  National clinical programmes in the Republic of Ireland: a qualitative study of acute hospitals.

Authors:  Geraldine Shaw
Journal:  J Res Nurs       Date:  2020-08-03

5.  Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study.

Authors:  S Mathoulin-Pélissier; C Chevreau; C Bellera; E Bauvin; M Savès; P Grosclaude; S Albert; J Goddard; S Le Guellec; M Delannes; B N Bui; J Mendiboure; E Stoeckle; J M Coindre; G Kantor; M Kind; A Cowppli-Bony; S Hoppe; A Italiano
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

6.  Selecting high priority quality measures for breast cancer quality improvement.

Authors:  Michael J Hassett; Melissa E Hughes; Joyce C Niland; Rebecca Ottesen; Stephen B Edge; Michael A Bookman; Robert W Carlson; Richard L Theriault; Jane C Weeks
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

7.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal:  BMJ       Date:  2010-08-11

8.  Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.

Authors:  Pierre Etienne Heudel; Philippe Cousin; Antoine Lurkin; Claire Cropet; Françoise Ducimetiere; Olivier Collard; Guy De Laroche; Pierre Biron; Pierre Meeus; Philippe Thiesse; Christophe Bergeron; Gualter Vaz; François Mithieux; Fadila Farsi; Yohan Fayet; François-Noel Gilly; Dominic Cellier; Jean-Yves Blay; Isabelle Ray-Coquard
Journal:  Int J Clin Oncol       Date:  2013-08-10       Impact factor: 3.402

9.  Breast cancer care compared with clinical Guidelines: an observational study in France.

Authors:  Marie Lebeau; Simone Mathoulin-Pélissier; Carine Bellera; Christine Tunon-de-Lara; Alain Daban; Francis Lipinski; Dominique Jaubert; Pierre Ingrand; Virginie Migeot
Journal:  BMC Public Health       Date:  2011-01-20       Impact factor: 3.295

10.  The quality of web-based oncology guidelines and protocols: how do international sites stack up?

Authors:  J M Langton; A K Drew; L Mellish; J Olivier; R L Ward; S-A Pearson
Journal:  Br J Cancer       Date:  2011-09-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.